OBJECTIVE: An examination of clinically relevant subgroups of patients in the MARINA
study of ranibizumab in treatment of minimally classic or occult with no classic choroidal …

… Dr Acharya was a research fellow at Genentech. Involved in conception and design of study
(PKK, DB, HH, SS, NA); analysis and interpretation of data (PKK, DB, KZ, FH, HS, SS, NA); …

Objective To compare topical natamycin vs voriconazole in the treatment of filamentous
fungal keratitis. Methods This phase 3, double-masked, multicenter trial was designed to …

… Author Contributions: Dr Acharya had full access to all the data in the study and takes …
Funding/Support: Dr Acharya’s work was supported by National Eye Institute grant K23EY017897, …

JIA-associated uveitis carries significant ocular morbidity that lasts well into adulthood.
Treatment with immunosuppressive agents can reduce the risk of ocular complications. Biologic …

OBJECTIVE: To assess pharmacodynamic responses to ranibizumab, an inhibitor of vascular
endothelial growth factor A (VEGF-A), in a study of the treatment of minimally classic or …

Objective To conduct a therapeutic exploratory clinical trial comparing clinical outcomes of
treatment with topical natamycin vs topical voriconazole for fungal keratitis. Methods The …

Objective To determine whether there is a benefit in clinical outcomes with the use of topical
corticosteroids as adjunctive therapy in the treatment of bacterial corneal ulcers. Methods …

Pediatric uveitis is a relatively rare clinical entity that can have severe visual repercussions
if not diagnosed and treated appropriately. The complications associated with this disease …

Aims International criteria for the diagnosis of ocular sarcoidosis (OS) was established by the
first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed …